HR 3017
PI Post Acute Access Act
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
This bill, the PI Post Acute Access Act, aims to improve access to care for Medicare patients with primary immune deficiency diseases. It specifically allows skilled nursing facilities to receive separate Medicare payments for the supplies and services required to administer intravenous immune globin (IVIG), a treatment used to manage these rare genetic disorders. This change ensures that facilities can adequately support patients receiving this crucial therapy. The bill takes effect on January 1, 2024.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsor
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.